Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203788 · ClinicalTrials.gov registry record · Phase 4
Improving Work Outcome in People With Recent-onset Schizophrenia
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 87
- Enrollment target
NCT00203788 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 87 participants.
The verdict
NCT00203788, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining work or school activities in people with recent-onset schizophrenia.
Interventions
- BEHAVIORAL Individual Placement and Support
- BEHAVIORAL Workplace Fundamentals Module
- BEHAVIORAL Brokered Vocational Rehabilitation
- DRUG Oral risperidone
- BEHAVIORAL Skills training group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 1999-05 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203788
The ClinicalTrials.gov registry entry for NCT00203788 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Individual Placement and Support is the first listed.
NCT00203788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203788 about?
NCT00203788 is a clinical study titled "Improving Work Outcome in People With Recent-onset Schizophrenia". This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining w...
What is the current status of trial NCT00203788?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 87 participants. The study started on 1999-05. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00203788?
The interventions under investigation include: Individual Placement and Support (BEHAVIORAL), Workplace Fundamentals Module (BEHAVIORAL), Brokered Vocational Rehabilitation (BEHAVIORAL), Oral risperidone (DRUG), Skills training group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00203788?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.